An inevitable dilemma: Prenatal testing for mutations in the brca1 breast-ovarian cancer susceptibility gene

Obstetrics & Gynecology - Tập 87 - Trang 306-309 - 1996
Johnathan M. Lancaster1,2, Roger W. Wiseman1,2, Andrew Berchuck1,2
1From the Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, USA
2From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA